Faes Farma SA FAE
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €3.60
- Day Range
- €3.57–3.67
- 52-Week Range
- €2.87–3.67
- Bid/Ask
- — / —
- Market Cap
- €1.14 Bil
- Volume/Avg
- 305,406 / 227,833
Key Statistics
- Price/Earnings (Normalized)
- 9.98
- Price/Sales
- 2.61
- Dividend Yield (Trailing)
- 1.07%
- Dividend Yield (Forward)
- 1.07%
- Total Yield
- 2.62%
Company Profile
Faes Farma SA is a pharmaceutical company that specializes in the research, production, distribution, and sale of prescription and generic drugs, over-the-counter medicines, food supplements and personal care treatments, as well as raw materials for the pharmaceutical use. The company develops new drugs for the treatment of allergy, venous insufficiency, and irritable bowel syndrome. It also provides animal nutrition products. Faes Farma exports its products to more than 60 countries and has operations in Spain, Portugal, Chile, and Mexico, among others.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,761
- Website
- http://www.faes.es
Comparables
Valuation
|
Metric
|
FAE
|
008930
|
PROC
|
|---|---|---|---|
Price/Earnings (Normalized) | 9.98 | 22.47 | 87.39 |
Price/Book Value | 1.71 | 2.85 | 7.62 |
Price/Sales | 2.61 | 1.85 | 0.66 |
Price/Cash Flow | 9.97 | 37.87 | 5.91 |
Price/Earnings
FAE
008930
PROC
Financial Strength
|
Metric
|
FAE
|
008930
|
PROC
|
|---|---|---|---|
Quick Ratio | 1.85 | — | 0.97 |
Current Ratio | 3.34 | 0.67 | 1.47 |
Interest Coverage | 266.72 | 13.78 | 2.77 |
Quick Ratio
FAE
008930
PROC
Profitability
|
Metric
|
FAE
|
008930
|
PROC
|
|---|---|---|---|
Return on Assets (Normalized) | 12.46% | 10.01% | 0.21% |
Return on Equity (Normalized) | 14.75% | 15.05% | 7.45% |
Return on Invested Capital (Normalized) | 14.15% | 12.80% | 10.39% |
Return on Assets
FAE
008930
PROC
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Qhklfpzfs | Nsxz | $79.4 Bil | |
MKKGY
| Merck KGaA ADR | Jzkpjmxkn | Hcgzy | $79.0 Bil | |
HLN
| Haleon PLC ADR | Bzwcmqrwg | Lznrd | $38.5 Bil | |
VTRS
| Viatris Inc | Qngydlfz | Kbmp | $13.1 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Qqdpphbf | Mflms | $11.7 Bil | |
CTLT
| Catalent Inc | Gtxjchxy | Gbhbdn | $10.0 Bil | |
CURLF
| Curaleaf Holdings Inc | Pvpgwwdl | Xwr | $4.2 Bil | |
PRGO
| Perrigo Co PLC | Ycvcvbq | Hgqjd | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Hbvqprtt | Knmlwj | $3.2 Bil | |
GTBIF
| Green Thumb Industries Inc | Cyvvnqcjw | Glq | $3.1 Bil |